ZA200605713B - Transdermal delivery system of hormones without penetration enhancers - Google Patents

Transdermal delivery system of hormones without penetration enhancers

Info

Publication number
ZA200605713B
ZA200605713B ZA2006/05713A ZA200605713A ZA200605713B ZA 200605713 B ZA200605713 B ZA 200605713B ZA 2006/05713 A ZA2006/05713 A ZA 2006/05713A ZA 200605713 A ZA200605713 A ZA 200605713A ZA 200605713 B ZA200605713 B ZA 200605713B
Authority
ZA
South Africa
Prior art keywords
hormones
delivery system
transdermal delivery
penetration enhancers
enhancers
Prior art date
Application number
ZA2006/05713A
Other languages
English (en)
Inventor
Petra Huber
Thomas Langguth
Dirk Schenk
Michael Dittgen
Stefan Bracht
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34702342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200605713(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA200605713B publication Critical patent/ZA200605713B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
ZA2006/05713A 2003-12-12 2006-07-11 Transdermal delivery system of hormones without penetration enhancers ZA200605713B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52871803P 2003-12-12 2003-12-12
EP03078881 2003-12-12
PCT/IB2004/052752 WO2005058287A2 (fr) 2003-12-12 2004-12-10 Administration transdermique d'hormones sans utilisation d'un agent facilitant la penetration

Publications (1)

Publication Number Publication Date
ZA200605713B true ZA200605713B (en) 2008-01-08

Family

ID=34702342

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2006/05713A ZA200605713B (en) 2003-12-12 2006-07-11 Transdermal delivery system of hormones without penetration enhancers

Country Status (15)

Country Link
JP (1) JP4965263B2 (fr)
KR (1) KR101168449B1 (fr)
CN (1) CN1913878B (fr)
AU (1) AU2004298930B2 (fr)
BR (1) BRPI0417530B8 (fr)
CA (1) CA2549916C (fr)
CU (1) CU23868B1 (fr)
EA (1) EA011160B1 (fr)
EC (1) ECSP066694A (fr)
IL (1) IL176112A (fr)
MX (1) MXPA06006682A (fr)
NO (1) NO341989B1 (fr)
NZ (1) NZ548091A (fr)
WO (1) WO2005058287A2 (fr)
ZA (1) ZA200605713B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05008778A (es) 2003-02-21 2006-05-25 Schering Ag Emplaste transdermico estable a uv.
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
FR2900048B1 (fr) * 2006-04-21 2012-11-16 Oreal Compositions comprenant un derive diphenyl-methane hydroxyle
AU2015203180B2 (en) * 2010-09-06 2016-06-30 Bayer Intellectual Property Gmbh Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
LT2613772T (lt) 2010-09-06 2017-03-27 Bayer Intellectual Property Gmbh Mažos dozės transderminiai pleistrai, pasižymintys aktyviu vaisto atpalaidavimu
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
AU2013212005A1 (en) * 2012-01-27 2014-07-31 Agile Therapeutics, Inc. Transdermal hormone delivery
MX2017014768A (es) * 2015-05-18 2018-03-23 Agile Therapeutics Inc Composiciones anticonceptivas y metodos para mejorar la eficacia y modulacion de los efectos secundarios.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0370220B1 (fr) * 1988-10-27 1996-01-10 Schering Aktiengesellschaft Composition de Gestoden à application transdermique
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
WO1992007590A1 (fr) * 1990-10-29 1992-05-14 Alza Corporation Compositions, procedes et dispositifs contraceptifs transdermiques
DE4329242A1 (de) * 1993-08-26 1995-03-02 Schering Ag Mittel zur transdermalen Applikation enthaltend Gestodenester
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
US5820878A (en) * 1994-11-18 1998-10-13 Hisamitsu Pharmaceutical Co., Inc. Percutaneously absorbable patch
EP0836506B2 (fr) * 1995-06-07 2011-12-21 Ortho-McNeil Pharmaceutical, Inc. Timbre transdermique pour l'administration de 17-deacetyl norgestimate en combinaison avec un estrogene
JP4346696B2 (ja) * 1996-05-28 2009-10-21 久光製薬株式会社 経皮治療用装置
JP4167750B2 (ja) * 1997-04-16 2008-10-22 久光製薬株式会社 経皮吸収用基剤及び該基剤を含有する経皮吸収製剤
JP4399044B2 (ja) * 1998-10-14 2010-01-13 久光製薬株式会社 吸収促進剤及び該吸収促進剤を有してなる経皮吸収製剤
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
EP1197212A4 (fr) * 1999-07-01 2004-06-02 Hisamitsu Pharmaceutical Co Preparation adhesive pour absorption percutanee
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
AU2002235155A1 (en) * 2000-12-05 2002-06-18 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems

Also Published As

Publication number Publication date
CU23868B1 (es) 2013-03-27
EA011160B1 (ru) 2009-02-27
CA2549916A1 (fr) 2005-06-30
KR101168449B1 (ko) 2012-07-25
BRPI0417530B1 (pt) 2018-01-23
CU20100143A7 (es) 2011-10-31
EA200601089A1 (ru) 2006-12-29
JP4965263B2 (ja) 2012-07-04
CN1913878B (zh) 2010-05-26
BRPI0417530B8 (pt) 2021-05-25
MXPA06006682A (es) 2006-08-11
NO341989B1 (no) 2018-03-12
AU2004298930B2 (en) 2009-11-26
AU2004298930A1 (en) 2005-06-30
IL176112A (en) 2011-02-28
CN1913878A (zh) 2007-02-14
NO20062594L (no) 2006-07-10
WO2005058287A2 (fr) 2005-06-30
BRPI0417530A (pt) 2007-03-13
ECSP066694A (es) 2006-10-31
KR20060128910A (ko) 2006-12-14
CA2549916C (fr) 2013-09-17
NZ548091A (en) 2009-12-24
WO2005058287A3 (fr) 2006-03-02
IL176112A0 (en) 2006-10-05
JP2007513938A (ja) 2007-05-31

Similar Documents

Publication Publication Date Title
HK1132682A1 (en) Transdermal delivery system of hormones without penetration enhancers
ZA200605713B (en) Transdermal delivery system of hormones without penetration enhancers
AU2003226605A8 (en) Handheld transdermal drug delivery and analyte extraction
IL173152A0 (en) Transdermal hormone delivery system: compositions and methods
EP1802258A4 (fr) Administration de medicament transdermique biosynchrone
IL174894A0 (en) Transdermal drug delivery device
EP1680178A4 (fr) Systeme et methode d'administration de vaccin transdermique
EP1680057A4 (fr) Dispositif et procede d'amelioration de l'administration transdermique de medicament
IL181436A0 (en) Transdermal antiemesis delivery system, method and composition therefor
EP1753380A4 (fr) Compositions adhesives formant une pellicule, pour l'administration dermique de medicaments et methodes d'utilisation desdites compositions
AU2003221770A8 (en) Controlled release transdermal drug delivery
EP1737357A4 (fr) Dispositif d'administration transdermique
IL178499A0 (en) Transdermal delivery system for use with basic permeation enhancers
EP1807033A4 (fr) Dispositif d'administration transdermique de medicaments avec couche support occlusive
ZA200711040B (en) Method and composition for transdermal drug delivery
AU2003265226A8 (en) Transdermal drug delivery device, method and use
EP1768742A4 (fr) Systeme d'administration pour immunisation transdermique
HK1106459A1 (en) Method of assembly of drug delivery devices
EP1796676A4 (fr) Administration transdermique de phycotoxines
AT500095B1 (de) Transdermales abgabesystem
EP1896038A4 (fr) Methode et composition pour l'administration transdermique d'un medicament
GB0810016D0 (en) Method and system for transdermal drug delivery
IL179675A0 (en) System and method for transdermal delivery of an anticoagulant
AU2003241134A1 (en) Transdermal drug delivery system
EP1547595A4 (fr) Pastille servant a effectuer une administration transdermique